Is this true and are 49.3 percent of indians non responders to minoxidil
Searching PubMed
SULT1A1 minoxidil non-responders Indians
Searching PubMed
minoxidil sulfotransferase SULT1A1 hair loss response ethnic
Searching the Web
49.3% Indians SULT1A1 minoxidil non-responders study
Searching PubMed
SULT1A1 minoxidil androgenetic alopecia response prediction
Searching the Web
SULT1A1 low activity prevalence Indian population percentage
Searching the Web
Chitalia 2018 follicular minoxidil sulfotransferase activity Indian subcontinent hair loss 49%
Reading Article
Reading Article
Now I have the full picture. Here's a thorough breakdown:
The 49.3% Figure - Is It True?
Yes, this is a real, published study. The exact figure comes from:
Chitalia J, Dhurat R, Goren A, et al. "Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian Subcontinent." Dermatologic Therapy, 2018. PMID 30295395
What the study actually found:
- 120 Indian pattern hair loss patients at a dermatology clinic in India were tested
- 49.3% of men had low sulfotransferase (SULT1A1) activity - this is the number being cited
- 26.6% of women had low activity
- Overall (men + women combined): 40.8% had low activity
- Low SULT1A1 activity was confirmed to predict poor response to topical minoxidil
So the "49.3% of Indians" claim is partially accurate but imprecise - the 49.3% applies specifically to Indian men, not Indians overall (the overall figure is 40.8%).
Why This Matters: The SULT1A1 Mechanism
Minoxidil is a prodrug. It does nothing on its own - the enzyme SULT1A1 in hair follicles must convert it to minoxidil sulfate, which is the active form that stimulates hair growth. People with low SULT1A1 activity in follicles simply cannot activate the drug adequately, so they won't respond regardless of how much they apply or for how long.
About the Panel in the Image
The post recommends testing:
| Category | Tests | Verdict |
|---|---|---|
| Hormonal | Serum DHT, Total/Free Testosterone, SHBG + Estradiol | Reasonable for investigating hormonal hair loss |
| Scalp-genetic | SULT1A1 DNA test, AR gene test, Trichoscopy | The SULT1A1 test has legitimate science behind it |
| Metabolic | Ferritin, Vit D, Zinc, hs-CRP, Fasting Insulin, HbA1c | These are real contributors to diffuse hair loss |
The tests listed are clinically reasonable - ferritin deficiency, vitamin D deficiency, thyroid issues, and insulin resistance are all known to worsen hair loss. The SULT1A1 test is backed by real research (as shown above).
However, a few caveats on the post's framing:
- The 49.3% figure is for men specifically, not all Indians
- The study had only 120 patients - a small, single-center sample
- SULT1A1 activity can be boosted (microneedling increases it in ~66% of subjects; topical tretinoin converts ~43% of predicted non-responders into responders) - so a "low" result doesn't mean minoxidil is useless
- Oral minoxidil bypasses much of the topical activation issue - it's absorbed systemically and SULT1A1 in multiple tissues can activate it
The claim that spending ₹17,000-32,000 on tests beats "wasting ₹50,000 on minoxidil that doesn't work for your phenotype" is a marketing angle - these tests are useful context but not necessarily prerequisites before trying minoxidil.
This is a shared conversation. Sign in to Orris to start your own chat.